GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Eurofins Scientific SE (XPAR:ERF) » Definitions » Cyclically Adjusted PS Ratio

Eurofins Scientific SE (XPAR:ERF) Cyclically Adjusted PS Ratio : 2.34 (As of Apr. 30, 2024)


View and export this data going back to 1997. Start your Free Trial

What is Eurofins Scientific SE Cyclically Adjusted PS Ratio?

As of today (2024-04-30), Eurofins Scientific SE's current share price is €58.70. Eurofins Scientific SE's Cyclically Adjusted Revenue per Share for the fiscal year that ended in Dec23 was €25.06. Eurofins Scientific SE's Cyclically Adjusted PS Ratio for today is 2.34.

The historical rank and industry rank for Eurofins Scientific SE's Cyclically Adjusted PS Ratio or its related term are showing as below:

XPAR:ERF' s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 2.1   Med: 4.9   Max: 8.36
Current: 2.26

During the past 13 years, Eurofins Scientific SE's highest Cyclically Adjusted PS Ratio was 8.36. The lowest was 2.10. And the median was 4.90.

XPAR:ERF's Cyclically Adjusted PS Ratio is ranked worse than
50.74% of 136 companies
in the Medical Diagnostics & Research industry
Industry Median: 2.235 vs XPAR:ERF: 2.26

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Eurofins Scientific SE's adjusted revenue per share data of for the fiscal year that ended in Dec23 was €32.919. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is €25.06 for the trailing ten years ended in Dec23.

Shiller PE for Stocks: The True Measure of Stock Valuation


Eurofins Scientific SE Cyclically Adjusted PS Ratio Historical Data

The historical data trend for Eurofins Scientific SE's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Eurofins Scientific SE Cyclically Adjusted PS Ratio Chart

Eurofins Scientific SE Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.90 4.57 5.92 3.06 2.35

Eurofins Scientific SE Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.92 - 3.06 - 2.35

Competitive Comparison of Eurofins Scientific SE's Cyclically Adjusted PS Ratio

For the Diagnostics & Research subindustry, Eurofins Scientific SE's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Eurofins Scientific SE's Cyclically Adjusted PS Ratio Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Eurofins Scientific SE's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Eurofins Scientific SE's Cyclically Adjusted PS Ratio falls into.



Eurofins Scientific SE Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Eurofins Scientific SE's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=58.70/25.06
=2.34

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Eurofins Scientific SE's Cyclically Adjusted Revenue per Share for the fiscal year that ended in Dec23 is calculated as:

For example, Eurofins Scientific SE's adjusted Revenue per Share data for the fiscal year that ended in Dec23 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Dec23 (Change)*Current CPI (Dec23)
=32.919/121.1700*121.1700
=32.919

Current CPI (Dec23) = 121.1700.

Eurofins Scientific SE Annual Data

Revenue per Share CPI Adj_RevenuePerShare
201412 8.781 98.830 10.766
201512 11.989 99.910 14.540
201612 14.959 101.040 17.939
201712 16.510 102.410 19.534
201812 20.662 104.320 23.999
201912 24.465 106.080 27.945
202012 27.763 106.670 31.537
202112 33.488 111.090 36.527
202212 33.729 117.060 34.913
202312 32.919 121.170 32.919

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Eurofins Scientific SE  (XPAR:ERF) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Eurofins Scientific SE Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of Eurofins Scientific SE's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Eurofins Scientific SE (XPAR:ERF) Business Description

Traded in Other Exchanges
Address
23 Val Fleuri, Luxembourg, LUX, L-1526
Eurofins, headquartered in Luxembourg, is a decentralized network of life sciences companies that provide various analytical tests and laboratory services. These include tests to evaluate the safety, identity, composition, authenticity, purity, origin, and traceability of various biological substances and products. Eurofins operates over 900 laboratories in 61 countries. Its revenue from Europe, North America, and the Rest of the World contribute approximately 50%, 40%, and 10% of total revenue respectively. Its main business activities are food and environmental testing, biopharmaceutical services, diagnostic services and products, and consumer and technology products testing, which contribute approximately 40%, 30%, 20%, and 10% respectively.

Eurofins Scientific SE (XPAR:ERF) Headlines

From GuruFocus

Enerplus: Investors Need to Consider This Stock for the Long Run

By Thriftyinvestments Thriftyinvestments 05-13-2015

Why Investors Should Be Cautious About Enerplus in the Short Run

By RHPanalysts RHPanalysts 05-24-2015

Enerplus Corporation Is a Stock to Stay Away From

By MacroConsultants MacroConsultants 04-27-2015

ADVISORY RESEARCH INC Buys 3, Sells 2 in 2nd Quarter

By GuruFocus Research GuruFocus Editor 08-17-2022

ERF 8.2% Yield Put into Perspective

By Ilia Frankstein Ilia Frankstein 10-10-2011